Discover

REGN
Regeneron Pharmaceuticals, Inc.
797.00
1 x 795.00
1 x 808.37
bid
ask
-
11.05
1.37%
1 @ 04:00 PM
797.00 +0.00 (0.00%)
Ytd3.26%
1y45.99%
796.66
day range
813.63
541.00
52 week range
821.11
Open805.96Prev Close808.05Low796.66High813.63Mkt Cap82.11B
Vol591.27KAvg Vol1.02MEPS45.63P/E17.47Forward P/E13.05
Beta0.19Short Ratio3.60Inst. Own94.70%Dividend3.76Div Yield0.48
Ex Div Date08-18Earning07-3050-d Avg660.44200-d Avg715.741yr Est833.54

REGN News

REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?
zacks.com
REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?

Regeneron's Eylea HD and Dupixent strength are fueling growth, while oncology gains and pipeline pro

REGN DEADLINE: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
REGN DEADLINE: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Secu

NEW YORK, Aug. 11, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholde

REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com
REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Cla

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit
prnewswire.com
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportun

SAN FRANCISCO, Aug. 11, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Reg

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit wit

LOS ANGELES, Aug. 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN
globenewswire.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regenero

Regeneron's clinical-trial risk disclosures are under scrutiny after allegations that the Company mi

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP
prnewswire.com
Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron

SAN FRANCISCO, Aug. 10, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Reg

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Acti

New York, New York--(Newsfile Corp. - August 9, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nation

Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
globenewswire.com
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action L

SAN FRANCISCO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in

REGN Deadline Alert: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of Securities Class Action Deadline on September 14, 2026
globenewswire.com
REGN Deadline Alert: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareh

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit wit

LOS ANGELES, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l

REGN UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com
REGN UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Ph

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit
prnewswire.com
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportun

SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Rege

SueWallSt Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
prnewswire.com
SueWallSt Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lea

Institutional investors with REGN positions may need to assess alleged clinical-trial disclosure fai

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit – Hagens Berman
globenewswire.com
Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron

SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in

Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock
zacks.com
Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock

Regeneron (REGN) shares have started gaining and might continue moving higher in the near term, as i

REGN or INCY: Which Is the Better Value Stock Right Now?
zacks.com
REGN or INCY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
feeds.newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Acti

New York, New York--(Newsfile Corp. - August 5, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nati

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Acti

New class action for Regeneron (REGN) urges investors to seek recovery for alleged securities fraud

REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky
prnewswire.com
REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmac

Ryan Crowe Regeneron securities defendant liability allegations focus on investor-facing statements

REGN Stock Drop: If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Leading the Class Action Lawsuit
businesswire.com
REGN Stock Drop: If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP

SAN DIEGO, Calif.--(BUSINESS WIRE)---- $REGN #Health--Robbins LLP reminds investors that a securitie

REGN EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com
REGN EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Ac

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Ph

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN)
globenewswire.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit
prnewswire.com
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportun

SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Rege

REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt
globenewswire.com
REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Secu

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SueWallSt alerts investors in Regeneron Pharmaceuticals,

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit wit

LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l

Regeneron (REGN) is a Top-Ranked Value Stock: Should You Buy?
zacks.com
Regeneron (REGN) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN
prnewswire.com
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regene

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholder

REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action for Investors
prnewswire.com
REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action f

A securities fraud class action lawsuit has been filed on behalf of Regeneron investors after its st

6 Health Care Stocks Whale Activity In Today’s Session
benzinga.com
6 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

10 Health Care Stocks With Whale Alerts In Today’s Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfolio
benzinga.com
Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfo

For the tens of millions of Americans who cannot push their LDL cholesterol (trivially known as &#34

Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness
benzinga.com
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after recei

benzinga.com
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Re

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

benzinga.com
CytomX Expands Collaboration And Licensing Agreement With Regeneron To Create Conditionally-Activate

- Expanded collaboration builds upon research momentum in developing next-generation bispecific immu

10 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session

Nasdaq 100 Drops Over 1%, Oil Tops $106 On Iran Impasse: Stock Market Today
benzinga.com
Nasdaq 100 Drops Over 1%, Oil Tops $106 On Iran Impasse: Stock Market Today

Nasdaq sinks 1.1% as AMAT, MU, ORCL and Vertiv crater on AI capex jitters, while WTI tops $106 and t

Nvidia To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Monday
benzinga.com
Nvidia To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts changed outlook on top names. Keybanc, Leerink, Wedbush, DA Davidson, Benchmark, Piper

UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Ses

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Mon

Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $

Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Friday
benzinga.com
Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Friday

Citigroup cut RCL's price target, TD Cowen raised COHU's price target, JP Morgan cut SYK&#39

Oil Surges 6%, S&P 500 Wobbles Before Fed And Tech Earnings: Stock Market Today
benzinga.com
Oil Surges 6%, S&P 500 Wobbles Before Fed And Tech Earnings: Stock Market Today

Crude oil rocketed nearly 6% on a stalled US-Iran standoff while stocks drifted lower ahead of the F

Earnings Scheduled For April 29, 2026
benzinga.com
Earnings Scheduled For April 29, 2026

4 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
4 Health Care Stocks With Whale Alerts In Today's Session

JPMorgan, Allogene Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
JPMorgan, Allogene Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures mixed, Nasdaq 100 up over 50 points. JPMorgan shares down 3.1% after beating earnin

From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker
benzinga.com
From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker

Sanofi reports positive Phase 2 data for lunsekimig in asthma and nasal polyps, while atopic dermati

This Regeneron Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
This Regeneron Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations

Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrade

Why Is CRISPR Therapeutics Stock Surging Thursday?
benzinga.com
Why Is CRISPR Therapeutics Stock Surging Thursday?

CRSP shares jump on earnings report, strong pipeline for gene therapy. Revenue grows with increased